Troy– Author –
-
20th World Drug Delivery Summit in London in June to Focus on Nanoparticle DDS Market Trends, Investment Opportunities, and Clinical Trials
Conference Series UK Overview The 20th World Drug Delivery Summit, held in London on June 8-9, 2026, will focus on how nanoparticles, including liposomes, micelles, and polymeric nanoparticles, enhance drug efficacy and targeted delivery... -
ACS Omega Reports Ag-Coated TiO2 Nanoparticle-Reinforced PLA Nanofiber Mats Exhibit Antibacterial Activity Against Gram-Positive and Gram-Negative Bacteria, Opening New Avenues for Wound Dressings
ACS Publications USA Overview Research published in ACS Omega reports the development of electrospun poly(lactic acid) (PLA) nanofiber mats reinforced with silver-coated titanium dioxide (Ag@TiO2) nanoparticles, demonstrating excellent a... -
Lucintel Forecasts Global Carbon Nanotube (CNT) Market to Reach $6.197 Billion by 2035 with 14.7% CAGR, Driven by EV, Semiconductor, and Nanotechnology R&D
Barchart.com USA Overview This article provides an overview of a market research report by Lucintel. The global Carbon Nanotube (CNT) market is projected to grow at a Compound Annual Growth Rate (CAGR) of 14.7% from 2026 to 2035, reachin... -
CSIR-IICT Develops MOF/Graphene-Enhanced Nanofiber Membrane Achieving 99.1% Dye Removal for Textile Wastewater Treatment, Contributing to India’s ‘Zero Discharge’ Goal
Apparel Resources News-Desk India Overview Scientists at India's CSIR-IICT have developed a high-performance electrospun nanofiber membrane for textile wastewater treatment, achieving an impressive 99.1% dye removal efficiency. This comp... -
Cartesian Therapeutics Licenses WestGene LNP Technology, Initiates Phase 1 for In Vivo CAR-T Descartes-08 in Myasthenia Gravis, Streamlining Manufacturing
Biospace USA Overview Cartesian Therapeutics announced a strategic licensing agreement with WestGene Biopharma to accelerate its in vivo CAR-T platform development using WestGene’s targeted lipid nanoparticle (LNP) technology. This colla... -
Moderna-Merck Cancer Vaccine Enters Phase 3, mRNA Therapeutics LNP Manufacturing Scales Beyond 17 L/hr, Rare Metabolic Disease Drugs Nearing Approval Studies
BioProcess International USA Overview Six key developments are shaping mRNA therapeutics beyond COVID-19 vaccines: Moderna and Merck's personalized cancer vaccine has advanced to Phase 3 trials, and rare metabolic disease drugs like mRNA... -
China’s Prinano Achieves Mass Production of 8-inch Photonic Chips with Proprietary Nanoimprint Tech, Bypassing ASML Equipment, Reducing Cost by 10x, and Achieving Sub-10nm Resolution to Circumvent Export Controls
South China Morning Post China Overview Chinese startup Prinano announced successful mass production of photonic chips on 8-inch silicon wafers using its proprietary PL-AS vacuum air-cushion nanoimprint lithography (NIL) equipment, elimi... -
AZoNano Report Details Nanomaterials Powering Green Energy Transition: Graphene, CNTs, and Quantum Dots Revolutionize Batteries, Solar Cells, and Hydrogen Tech
AZoNano Australia Overview An AZoNano report details how nanomaterials like graphene, carbon nanotubes (CNTs), and quantum dots (QDs) are revolutionizing green energy by enhancing charge transport, catalytic efficiency, and light absorpt... -
FDA Endorses ‘Prior Knowledge’ Use in Gene Therapy Development, Streamlining Review for AAV, Nanoparticle Delivery Systems, and Cell Therapies
Hogan Lovells USA Overview The U.S. Food and Drug Administration (FDA) issued guidance endorsing the use of 'Prior Knowledge' in the development of genome editing products, a policy expected to streamline drug development and review proc... -
SON SAS Weekly Nanoparticle & Nanomaterials Report Highlights New Therapeutic Avenues for Cardiovascular Disease, Obesity, and Breakthrough Graphene Implants for Brain Tumors
SON SAS France Overview SON SAS's weekly news report on nanoparticles and nanomaterials highlighted notable advancements in materials opening new therapeutic pathways for cardiovascular disease and obesity, along with the development of ...
